Schonfeld Strategic Advisors LLC Immunic, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 16,600 shares of IMUX stock, worth $17,596. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,600

Previous 28,200 41.13%

Holding current value

$17,596

Previous $31,000 12.9%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.08 - $1.95 $12,528 - $22,620	-11,600 Reduced 41.13%	16,600 $27,000
Q2 2024 Aug 14, 2024	SELL	$0.98 - $1.44 $24,304 - $35,712	-24,800 Reduced 46.79%	28,200 $31,000
Q1 2024 May 15, 2024	SELL	$1.14 - $1.53 $87,437 - $117,351	-76,700 Reduced 59.14%	53,000 $69,000
Q4 2023 Feb 14, 2024	SELL	$0.97 - $1.6 $105,730 - $174,400	-109,000 Reduced 45.66%	129,700 $194,000
Q3 2023 Nov 14, 2023	BUY	$1.35 - $2.87 $86,130 - $183,106	63,800 Added 36.48%	238,700 $350,000
Q2 2023 Aug 14, 2023	BUY	$1.33 - $2.51 $55,727 - $105,168	41,900 Added 31.5%	174,900 $438,000
Q1 2023 May 15, 2023	BUY	$1.35 - $2.87 $179,550 - $381,710	133,000 New	133,000 $198,000
Q3 2022 Nov 14, 2022	BUY	$3.0 - $5.49 $8,100 - $14,823	2,700 Added 2.65%	104,400 $330,000
Q2 2022 Aug 15, 2022	BUY	$3.13 - $12.25 $64,791 - $253,575	20,700 Added 25.56%	101,700 $353,000
Q1 2022 May 16, 2022	BUY	$9.54 - $14.26 $235,637 - $352,222	24,700 Added 43.87%	81,000 $916,000
Q4 2021 Feb 14, 2022	BUY	$7.34 - $10.25 $13,946 - $19,475	1,900 Added 3.49%	56,300 $539,000
Q3 2021 Nov 16, 2021	BUY	$8.05 - $13.29 $28,175 - $46,515	3,500 Added 6.88%	54,400 $482,000
Q2 2021 Aug 16, 2021	BUY	$11.76 - $16.85 $103,488 - $148,280	8,800 Added 20.9%	50,900 $624,000
Q1 2021 May 17, 2021	BUY	$14.21 - $25.3 $35,525 - $63,250	2,500 Added 6.31%	42,100 $671,000
Q4 2020 Feb 16, 2021	SELL	$14.8 - $20.37 $766,640 - $1.06 Million	-51,800 Reduced 56.67%	39,600 $605,000
Q3 2020 Nov 16, 2020	BUY	$11.74 - $22.0 $651,570 - $1.22 Million	55,500 Added 154.6%	91,400 $2,000
Q2 2020 Aug 14, 2020	BUY	$5.67 - $15.86 $203,553 - $569,374	35,900 New	35,900 $435,000

Others Institutions Holding IMUX

# of Institutions

Shares Held

56.2M

Call Options Held

100

Put Options Held

350K

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $32.4M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Immunic, Inc. Transaction History